The Thoracic Surgery Program at King Abdulaziz Medical City in Jeddah has announced the establishment of the Hyperthermic Intrathoracic Chemotherapy (HITHOC) service, a highly specialized and advanced therapeutic option that represents a significant addition to the treatment of advanced thoracic malignancies and provides patients with access to modern, advanced therapeutic options.
This development strengthens the medical city’s capability to deliver advanced therapeutic services to patients in the Western Region, enabling them to receive specialized care closer to home. It also marks a pivotal step toward achieving the medical city’s vision of becoming a referral center within the Ministry of National Guard Health Affairs for patients requiring this type of treatment.
The launch of this service highlights the essential role of a multidisciplinary medical team, with contributions from thoracic surgeons, anesthesiologists, intensivists, oncologists, nursing staff, pharmacists, and other healthcare professionals who played a key role in supporting this important advancement.
The Thoracic Surgery Program affirms its pride in this achievement and its commitment to further advancing thoracic oncology services and enhancing the quality of care provided to patients in the Western Region.